These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 25624048

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of the dual PI3K and mTOR inhibitor BEZ235 on tumour growth and osteolytic bone disease in multiple myeloma.
    Gan ZY, Fitter S, Vandyke K, To LB, Zannettino AC, Martin SK.
    Eur J Haematol; 2015 Apr; 94(4):343-54. PubMed ID: 25179233
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antitumor activity of NVP-BKM120--a selective pan class I PI3 kinase inhibitor showed differential forms of cell death based on p53 status of glioma cells.
    Koul D, Fu J, Shen R, LaFortune TA, Wang S, Tiao N, Kim YW, Liu JL, Ramnarian D, Yuan Y, Garcia-Echevrria C, Maira SM, Yung WK.
    Clin Cancer Res; 2012 Jan 01; 18(1):184-95. PubMed ID: 22065080
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone.
    Zheng Y, Yang J, Qian J, Zhang L, Lu Y, Li H, Lin H, Lan Y, Liu Z, He J, Hong S, Thomas S, Shah J, Baladandayuthapani V, Kwak LW, Yi Q.
    J Mol Med (Berl); 2012 Jun 01; 90(6):695-706. PubMed ID: 22207485
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of p38alpha mitogen-activated protein kinase prevents the development of osteolytic bone disease, reduces tumor burden, and increases survival in murine models of multiple myeloma.
    Vanderkerken K, Medicherla S, Coulton L, De Raeve H, Willems A, Lawson M, Van Camp B, Protter AA, Higgins LS, Menu E, Croucher PI.
    Cancer Res; 2007 May 15; 67(10):4572-7. PubMed ID: 17495322
    [Abstract] [Full Text] [Related]

  • 17. Blockade efficacy of MEK/ERK-dependent autophagy enhances PI3K/Akt inhibitor NVP-BKM120's therapeutic effectiveness in lung cancer cells.
    Ren H, Guo H, Thakur A, Zhang S, Wang T, Liang Y, Shi P, Gao L, Liu F, Feng J, Chen T, Yang T, Shang D, Liu JJ, Xu F, Chen M.
    Oncotarget; 2016 Oct 11; 7(41):67277-67287. PubMed ID: 27572309
    [Abstract] [Full Text] [Related]

  • 18. [Phosphatidylinositide 3-kinase inhibitor BKM120 suppresses proliferation and promotes apoptosis of U251 glioblastoma cells].
    Qiu Z, Yue S, Chang J, Wang G.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul 11; 32(7):936-9. PubMed ID: 27363276
    [Abstract] [Full Text] [Related]

  • 19. Pathogenesis and management of myeloma bone disease.
    Christoulas D, Terpos E, Dimopoulos MA.
    Expert Rev Hematol; 2009 Aug 11; 2(4):385-98. PubMed ID: 21082944
    [Abstract] [Full Text] [Related]

  • 20. BKM120 induces apoptosis and inhibits tumor growth in medulloblastoma.
    Zhao P, Hall J, Durston M, Voydanoff A, VanSickle E, Kelly S, Nagulapally AB, Bond J, Saulnier Sholler G.
    PLoS One; 2017 Aug 11; 12(6):e0179948. PubMed ID: 28662162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.